Tetra Discovery Partners, Inc.

Tetra Discovery Partners, Inc.

Tetra Discovery Partners, Inc.

Overview
Date Founded

2011

Headquarters

4717 Campus Drive,Suite 1700,Kalamazoo, MI 49008

Type of Company

Private

Industries

Biotechnology
Holding Companies
Pharmaceuticals

Company Description

Tetra Discovery Partners, Inc. develops drugs for neurological disorders. It also develops medicines for Alzheimer's disease, traumatic brain injury, other dementias, major psychiatric diseases, Huntington's disease, and depression. The company was founded by Mark E. Gurney in 2011 and is headquartered in Grand Rapids, MI.

Executives & Employees

Chairman & Chief Executive Officer

Chief Medical Officer

Vice President, Clinical Operations

Executive Officer

Executive Officer

Executive Officer

Professional

Board of Directors

Chief Executive Officer at Tetra Therapeutics Inc.

General Partner at APJohn Ventures Annex Fund LP

Fund Advisor at Hopen LS Manager II LLC

Managing Director at Trout Creek Ventures LP

Executive Officer at Tetra Discovery Partners LLC

Executive Officer at Tetra Discovery Partners LLC

Paths to Tetra Discovery Partners, Inc.
Potential Connections via
Relationship Science
You
Tetra Discovery Partners, Inc.
Recent Transactions
Details Hidden

Tetra Discovery Partners, Inc. raised money in a private placement transaction

Details Hidden

Tetra Discovery Partners, Inc. raised money in a private placement transaction

Investors
Details Hidden

Dolby Family Ventures (Dolby) is a venture capital firm partners with companies in the U.S and internationally. Dolby invest meaningfully at the seed and early stage and later stage. It invests in companies as part of a strong syndicate of co-investors. The firm makes initial investments at the seed stage or in the Series A financing round. Dolby invests in Digital media, Security, Cloud service and Healthcare technologies and services. The firm makes co-investments and follow on investments and also takes board sit.

Details Hidden

The Alzheimer’s Drug Discovery Foundation was established in 2004 as a public charity to support the advancement of drugs to prevent, treat, and cure Alzheimer’s disease, related dementias, and cognitive aging. This strategy of venture philanthropy is based on the idea that research grant recipients are engaged in projects that are potentially viable in the marketplace with a possible return on investment.

Details Hidden

Apjohn Group LLC invests in pharamaceutical companies. It works with innovators to launch life science companies. The company is headquartered in Kalamazoo, MI.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Tetra Discovery Partners, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Tetra Discovery Partners, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Tetra Discovery Partners, Inc..